Theo Nicholaou
Austin Hospital(AU)Ludwig Cancer Research(AU)
Publications by Year
Research Areas
Immunotherapy and Immune Responses, vaccines and immunoinformatics approaches, T-cell and B-cell Immunology, Immune Cell Function and Interaction, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → An Open-Label, Two-Arm, Phase I Trial of Recombinant Human Interleukin-21 in Patients with Metastatic Melanoma(2007)165 cited
- → Regulatory T-Cell–Mediated Attenuation of T-Cell Responses to the NY-ESO-1 ISCOMATRIX Vaccine in Patients with Advanced Malignant Melanoma(2009)118 cited
- → Directions in the immune targeting of cancer: Lessons learned from the cancer‐testis Ag NY‐ESO‐1(2006)115 cited
- → Melan-A–specific Cytotoxic T Cells Are Associated with Tumor Regression and Autoimmunity Following Treatment with Anti-CTLA-4(2009)97 cited
- → Immunoediting and persistence of antigen-specific immunity in patients who have previously been vaccinated with NY-ESO-1 protein formulated in ISCOMATRIX™(2011)49 cited
- → Tumour lysis syndrome in a patient with renal-cell carcinoma treated with sunitinib malate(2007)27 cited
- → Phase II trial of vaccination with full length NY-ESO-1/IMX in patients with advanced malignant melanoma(2006)1 cited
- Protein-based vaccination targeting the cancer testis antigen NY-ESO-1(2008)